Tag: Intravascular lithotripsy
Shockwave Javelin peripheral IVL catheter meets prespecified efficacy and safety performance goals in feasibility and IDE studies
Shockwave Medical, part of Johnson & Johnson MedTech, has announced the first clinical outco...
FastWave Medical announces successful 30-day first-in-human data on peripheral IVL technology
FastWave Medical has announced the 30-day results of its first-in-human (FIH) study using the co...
FastWave Medical secures multi-million dollar private financing within weeks
FastWave Medical recently announced the swift closure of an oversubscribed multi-million dolla...
AVS’s pulsatile IVL technology attracts an additional US$8.8 million to close US$28.8 million Series B round
AVS, an early-stage medical device company focused on safely and effectively treating severely c...
Funding secured to advance development of Pulse IVL system
AVS has announced that it raised US$20 million in Series B financing, which the company says will ac...
Shockwave Medical and Genesis MedTech obtain regulatory approval in China for intravascular lithotripsy
Shockwave Medical and Genesis MedTech Group announced today that they have successfully obtained app...
Cardiovascular Systems announces development of IVL technology for the treatment of coronary and peripheral arterial diseases
Cardiovascular Systems recently announced that it has made significant progress towards the commerci...
Shockwave completes enrolment in study of coronary intravascular lithotripsy
Shockwave Medical has completed enrolment in its US Food and Drug Administration (FDA) Investiga...
IVL has “changed the dynamics” of facilitating EVAR & TEVAR in calcified iliac arteries
Frank Arko (Charlotte, USA) talks to VEITHtv at the VEITHsymposium 2019 (19–23 November, New Yo...
Shockwave IVL can aid in eliminating recoil and dissection during below-the-knee angioplasty
George Adams (Raleigh, USA) talks to VEITHtv at the VEITHsymposium 2019 (19–23 November, New Yor...
Shockwave commences IVL study to support regulatory approval in Japan
Shockwave Medical has initiated the DISRUPT CAD IV study of its intravascular lithotripsy (IVL) ...
Shockwave study demonstrates strong safety and procedural success of coronary IVL in Europe
Shockwave Medical, a company which provides intravascular lithotripsy (IVL) to treat complex cal...
Keith Dawkins appointed as chief medical officer at Shockwave Medical
Shockwave Medical has appointed Keith D Dawkins as its chief medical officer. In a press release...
Shockwave initiates US pivotal study for coronary intravascular lithotripsy
Shockwave Medical has initiated its US Food and Drug Administration (FDA) Investigatio...
Intravascular Lithotripsy for coronary artery disease launched in Europe
Intravascular Lithotripsy (Shockwave Medical) is now available, on the European market, for the mana...
Intravascular lithotripsy: A novel technology for treating calcified coronary stenoses
Intravascular lithotripsy, or IVL (Shockwave), is a novel procedure that is designed to deliver ...
